Mirae Asset Celltrion Growth Fund
Scope
Date
~
-
Shareholder activism
Palliser Capital urges Samsung C&T reform for $25 bn value-up
London-based hedge fund Palliser Capital said on Wednesday that Samsung C&T Corp. is 63% intrinsically undervalued and could increase its value ...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Economy
Semiconductor export recovery powers S.Koreans’ income in Q3
A recovery in semiconductor exports led an increase in South Koreans’ income in the third quarter, although the earnings growth momentum may n...
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanwha to re-enter biopharma market, targeting biomaterials
South Korea’s Hanwha Group will re-enter the biopharmaceutical market to become the country’s sole producer of tris buffers, a key reage...
Dec 05, 2023 (Gmt+09:00)
-
Travel & Leisure
Seoul to build huge two-ring Ferris wheel for $700 mn
The Seoul Metropolitan Government on Sunday unveiled the design of a Ferris wheel, tentatively named Seoul Twin Eye, which it plans to complete by 2...
Dec 04, 2023 (Gmt+09:00)
-
Executive reshuffles
LG Energy's new CEO aims to focus on qualitative growth
LG Energy Solution Ltd., the world’s second-largest electric vehicle battery maker, is set to focus on qualitative growth by securing leading ...
Dec 01, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung, SK Hynix expect high 2024 profits as memory market returns
Samsung Electronics Co. and SK Hynix Inc., the world’s two largest memory chipmakers, expect to post decent chip profits next year as DRAM pri...
Nov 30, 2023 (Gmt+09:00)
-
Central bank
BOK chief says rates need to stay high for over 6 months
South Korea’s central bank chief on Thursday said interest rates will have to stay high for more than six months, leaving the door open for an...
Nov 30, 2023 (Gmt+09:00)
-
Pension funds
NPS logs 8.7% return in Q1-Q3 on stock boom, strong dollar
National Pension Service (NPS) of South Korea posted an 8.66% investment return from January to September of this year with assets under management ...
Nov 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Nov 30, 2023 (Gmt+09:00)
-
Sovereign wealth funds
KIC recoups 40% of 2022’s loss on stock, bond gains
Korea Investment Corp. (KIC) posted a 7.12% return on total asset investments in the first eight months of this year, recouping about 40% of last ye...
Nov 29, 2023 (Gmt+09:00)
-
Corporate bonds
More Koreans seek high-yield bond funds, betting the Fed will end hikes
South Korean investors are growing more interested in global high-yield bond funds, betting that the US Federal Reserve is likely to end its interes...
Nov 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Eastspring Asset in Korea up for grabs at about $77 mn
Eastspring Asset Management Korea Co., the Korean operation of Prudential plc’s asset management unit, is up for sale for about 100 billion wo...
Nov 28, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Uplus to spur generative AI service for new growth: CEO
LG Uplus Corp., a leading mobile carrier in South Korea, is accelerating its generative artificial intelligence business as a new growth driver amid...
Nov 28, 2023 (Gmt+09:00)
-
Executive reshuffles
Samsung sets up future business planning unit, keeps co-CEO system
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, is creating a new division tasked with working out future ...
Nov 27, 2023 (Gmt+09:00)
-
Airlines
Korean LCC T’way enjoys healthy earnings on preemptive investment
South Korean budget airline T'way Air Co. reported strong earnings as it benefited from its preemptive move of introducing new aircraft to increase ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea to pour $26 bn in UK’s renewables, infrastructure
South Korea’s sovereign wealth fund, banks and other private sector companies plan to pour £21 billion ($26.3 billion) in renewables, in...
Nov 23, 2023 (Gmt+09:00)
-
Economy
Semiconductors likely to lead Korea’s export growth for 2nd month
South Korea’s semiconductor exports accelerated their recovery in the first 20 days of November, data showed on Tuesday, adding to hopes that ...
Nov 21, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Korean PE VIG Partners soaks up shampoo brand Kundal’s growth
South Korean private equity firm VIG Partners is enjoying rapid growth of The Skinfactory Co., the maker of local shampoo and body wash brand Kundal...
Nov 20, 2023 (Gmt+09:00)
-
Korean stock market
Thematic ETFs in Korea betting on India’s growth boom
South Korean asset managers stand hand in hand with their global peers in betting on India’s bright growth outlook by rolling out India-themed...
Nov 17, 2023 (Gmt+09:00)
-
Asset management
Samsung Asset launches 1st Korea-listed ETF in US
Samsung Asset Management Co., South Korea’s largest exchange-traded fund (ETF) manager, has launched an ETF in the US, the first of its kind t...
Nov 17, 2023 (Gmt+09:00)
-
Asset management
Investors roundtable: Watch out for a possible recession
Investors should carefully watch out for the probability of recession and how it will impact asset allocation strategies next year, experts said at ...
Nov 16, 2023 (Gmt+09:00)
-
Petrochemicals
Saudi Aramco’s $7 bn Korea project mired by labor shortage
Saudi Aramco’s $7 billion petrochemical project in South Korea, in what would be its largest-ever investment in the country, has hit a stumbli...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
-
Real estate
Mirae seeks sale of HK Goldin assets to recoup investment
Mirae Asset Securities Co., South Korea’s largest brokerage house, plans a public tender of assets held by debt-laden Goldin Financial Holding...
Nov 10, 2023 (Gmt+09:00)
-
Automobiles
Automotive supplier Hanon Systems delivers Q3 earnings shock
South Korea's Hanon Systems Corp., a world-leading heat pump systems maker for automobiles, on Thursday reported worse-than-expected results in the ...
Nov 09, 2023 (Gmt+09:00)
-
Economy
KDI cuts Korea growth forecasts, ups inflation predictions
A South Korean government think tank has cut its growth forecast in Asia’s fourth-largest economy for this year and next but raised inflation ...
Nov 09, 2023 (Gmt+09:00)
-
Asset management
Barings taps John Park as S.Korean asset management head
Barings LLC has appointed Chong Hak (John) Park as head and sole representative director of its South Korean asset management arm, effective Jan. 1,...
Nov 09, 2023 (Gmt+09:00)
-
Venture capital
VCs give thumbs up to EV, parts/materials, travel tech
The venture capital funding crunch has continued through this year in South Korea but VCs have raised their stakes in select companies in the electr...
Nov 09, 2023 (Gmt+09:00)